Lunger John

Lunger John is listed in filings as Chief Patient Supply Officer at Adaptimmune Therapeutics plc. This profile follows SEC Form 4 activity through Feb 20, 2025, including sale activity. Recent filings connect the profile to Adaptimmune Therapeutics plc (ADAPY). The current snapshot covers public activity from Jan 15, 2025 to Feb 20, 2025. Reported amounts are shown as $1.4K to $3.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.